About
Michael Chambers is the President and CEO of Swift Biotech. He has been a life-long entrepreneur. He received B.A. and J.D. degrees from the University of Alabama and a Ph.D. from the University of Geneva in Switzerland. He was the recipient of a Rotary Ambassadorial Scholarship and a Swiss Confederation Fellowship. He speaks fluent French and Spanish. Previously, Dr. Chambers helped establish InnoRx Pharmaceuticals in 1999, a company specializing in development of drugs and drug delivery systems for ocular disease. He served as President and CEO of InnoRx until negotiating its sale and merger into SurModics (NASDAQ: SRDX) in January 2005. Swift was one of three winners, among 50 competitors, of the 2010 Alabama Launchpad Business Plan competition for new technologies. Swift is developing several technologies in collaboration with the Mitchell Cancer Institute, including screens for endometrial and ovarian cancer, two of the leading causes of death in women in the United States.
Investment Focus
- Location
- Mobile, US
Contact Information
Find more investors like Michael
Search Investors